Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
gene editing
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
2
×
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
abbvie
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
allergan aesthetics
alzheimer's disease
amgen
andrew oxtoby
astrazeneca
athira pharma
attralus
What
bio
2
×
ceo
2
×
moves
roundup
week
2
×
acquisitions
big
biggest
bosley's
bosley’s
bridge
bucks
build
buy
cas
company’s
crime
crispr
daniel
debut
departure
drug
dyne’s
editas
exit
gilead
guiding
katrine
medicine
microbiome
openly
o’day
personnel
pipeline
sciences
scores
seagen
spoken
surprising
way
Language
unset
Current search:
bio
×
week
×
" seattle top stories "
×
ceo
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More